Colitis, Ulcerative: all 1,530 studies
Page 11 of 16. Open to participants first (407), then studies with results posted, then the rest; newest registration first within each.
- A Non-Interventional Pilot Study to Explore the Role of Gut Flora in DiseaseSuspendedNCT04031469
- Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative ColitisStatus unknownNCT04029649Phase 2/3
- Multistrain Probiotics Reduces UC Depression and Anxiety ScoresStatus unknownNCT04006977Not applicable
- Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative ColitisStatus unknownNCT04006080Phase 4
- Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative ColitisCompletedNCT04000139Phase 2
- Bmgim Music Therapy Method in Reducing Stress in Patients With Inflammatory Bowel DiseaseCompletedNCT03999294Not applicable
- Antimicrobial Therapy for Ulcerative Colitis (UC)TerminatedNCT03986996Phase 2
- Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous DiseaseCompletedNCT03983837Phase 2
- Combination of Diet and 5ASA ( 5-aminosalicylic Acid) for Ulcerative ColitisTerminatedNCT03980405Not applicable
- Phase II Study of Hemay007 in Patients With Active Ulcerative ColitisTerminatedNCT03977480Phase 2
- Development and Validation of a Deep Learning Algorithm to Evaluate Endoscopic Disease Activity of Ulcerative Colitis.Status unknownNCT03973437Not applicable
- Progression of Damage in Ulcerative ColitisStatus unknownNCT03955328Not applicable
- The PRECIOUS Study: Predicting Crohn's & ColitIs Outcomes in the United StatesStatus unknownNCT03952364
- Complications and Outcomes of Pouch ExcisionCompletedNCT03952195
- An Extension Study for Treatment of Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT03950232Phase 3
- Dynamic Changes of Gut Microbiota in UC After FMTStatus unknownNCT03949257Not applicable
- Fecal Transplant for Ulcerative ColitisCompletedNCT03948919Phase 1
- Russian Extremely Severe Ulcerative Colitis StudyCompletedNCT03947931
- Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol.Status unknownNCT03942861
- Impact of Additional Treatment With Saccharomyces Boulardii on Quality of Life in Patients With Mild Forms of Ulcerative Colitis and Crohn DiseaseStatus unknownNCT03941418Not applicable
- TITRATE (inducTIon for AcuTe UlceRATivE Colitis)TerminatedNCT03937609Phase 4
- ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative ColitisTerminatedNCT03923478Phase 1
- The Safety and Efficacy of TET Enema in the Treatment of UCStatus unknownNCT03917095Not applicable
- To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT03915769Phase 3
- COlonic Salvage by Therapeutic Appendectomy.CompletedNCT03912714Not applicable
- Electrical Vagal Nerve Stimulation in Ulcerative ColitisTerminatedNCT03908073Not applicable
- Multi-centre Acute Severe Ulcerative Colitis Prospective Cohort Study (Elevate ASUC)Active, not recruitingNCT03907631
- Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel DiseaseCompletedNCT03885713Phase 4
- Development and Validation of a Self-reported Objective Index of Work Disability in Inflammatory Bowel DiseaseStatus unknownNCT03872726
- Aquamin® as an Adjuvant Intervention for Ulcerative ColitisActive, not recruitingNCT03869905Phase 2
- Endoscopic Ultrasound Determines Disease Activity in Crohn's Disease And Ulcerative ColitisStatus unknownNCT03863886Not applicable
- GB004 in Adult Subjects With Active Ulcerative ColitisCompletedNCT03860896Phase 1
- A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT03849599Phase 1
- Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF TherapyCompletedNCT03847467Phase 1/2
- A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative ColitisTerminatedNCT03844932Phase 2
- Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitisActive, not recruitingNCT03843385Phase 3
- Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel DiseasesStatus unknownNCT03841045
- Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative ColitisStatus unknownNCT03839680
- Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC)CompletedNCT03832400Phase 1
- The Clinical Value of Chromoendoscopy as Surveillance Strategy for Dysplasia Detection in Ulcerative ColitisCompletedNCT03824418
- Relationship Between Baseline Burden of Disease and TDM in Ulcerative ColitisWithdrawnNCT03808506
- Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF（Tumor Necrosis Factor）TherapyTerminatedNCT03802214
- Lactobacillus Reuteri ATCC PTA 4659 in Ulcerative ColitisStatus unknownNCT03798210Phase 2
- Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative ColitisCompletedNCT03794765Phase 2
- Evaluation of Inflammation Activity in Ulcerative Colitis by pCLEStatus unknownNCT03788824
- PET Combined With MRI for Monitoring Inflammatory Activity in Patients With Ulcerative ColitisCompletedNCT03781284Not applicable
- Impact of a Physical Activity Program on Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowel DiseaseCompletedNCT03774329Not applicable
- Safety and Efficacy of PBF-677 in Ulcerative Colitis PatientsCompletedNCT03773952Phase 2
- Golimumab Trough Levels in Patients With Ulcerative ColitisCompletedNCT03773445
- Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center StudyTerminatedNCT03772145
- Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative ColitisTerminatedNCT03768219Phase 1
- Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative ColitisActive, not recruitingNCT03765450
- The Influence of Biologcal Treatment on the Short-Term Complications of Surgery in Patients With Inflematory Bowel Disease.CompletedNCT03747068
- Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative ColitisTerminatedNCT03724929Not applicable
- The Role of Secondary Bile Acids in Intestinal InflammationTerminatedNCT03724175Phase 2/3
- HF2 Therapy in the Treatment of Active Ulcerative ColitisCompletedNCT03720002Phase 1/2
- Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UCStatus unknownNCT03716388Phase 3
- The Effect of Fecal Microbiota Transplantation in Ulcerative ColitisCompletedNCT03711006Phase 1/2
- Open-label V565 Target Engagement StudyCompletedNCT03705117Phase 1
- A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative ColitisStatus unknownNCT03698812
- Specific microRNAs as Potential Biomarker for Inflammatory Bowel DiseaseStatus unknownNCT03698500Not applicable
- Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC)CompletedNCT03689673
- EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative ColitisCompletedNCT03679546Phase 4
- Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC)CompletedNCT03669822
- Optimization of Golimumab Treatment in Ulcerative ColitisStatus unknownNCT03669029Phase 4
- Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool SamplesCompletedNCT03663400
- One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort StudyCompletedNCT03662919
- Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune DiseaseTerminatedNCT03656627Phase 1
- A Study to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative ColitisWithdrawnNCT03627052Phase 2
- Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative ColitisStatus unknownNCT03609905Phase 1/2
- Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory DiseasesCompletedNCT03606499
- Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative ColitisTerminatedNCT03604536
- Immunonutrition in Ulcerative ColitisStatus unknownNCT03594708Not applicable
- Short Versus Long Interval to Ileostomy Reversal After Ileal Pouch SurgeryTerminatedNCT03587519Not applicable
- Capsulized Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis PatientsStatus unknownNCT03582969Phase 2
- Tolerability and Efficacy of Sodium Picosulfate/Magnesium Citrate Versus PEG/Ascorbic Acid in Ulcerative Colitis PatientsStatus unknownNCT03581149Phase 4
- Indicators Predicting Surgery in Acute Severe Ulcerative Colitis(ASUC)CompletedNCT03578692
- Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO)CompletedNCT03565939Phase 2
- Fecal Transplantation in Ulcerative ColitisStatus unknownNCT03561532Not applicable
- Pro-active Fecal Calprotectin Monitoring PROMOTE-UCCompletedNCT03549988
- Fecal Microbiota Transplantation for Chronic PouchitisCompletedNCT03538366Not applicable
- TAMIS-IPAA vs. Lap-IPAA for Ulcerative ColitiisStatus unknownNCT03536988Not applicable
- A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative ColitisCompletedNCT03531892Phase 3
- A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative ProctosigmoiditisTerminatedNCT03521232Phase 1/2
- A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)Active, not recruitingNCT03519945Phase 3
- COLISURG : Exploratory Analysis of Sexual Function and the Impact of Biotherapies on Postoperative Morbidity.Status unknownNCT03504930
- Predicting Relapse of Ulcerative Colitis With Gastrointestinal UltrasoundStatus unknownNCT03501758
- Hyperbaric Oxygen Therapy for Ulcerative Colitis FlaresCompletedNCT03494764Phase 2
- Impact of Fecal Microbiota Transplantation in Ulcerative ColitisActive, not recruitingNCT03483246Phase 3
- First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy VolunteersCompletedNCT03482648Phase 1
- Cytomegalovirus Infection in Steroid-refractory Ulcerative ColitisStatus unknownNCT03467841
- Digital Holographic Microscopy: Evaluation of Histological Disease Activity in Patients With Ulcerative ColitisStatus unknownNCT03464474Not applicable
- Fecal Microbiota Alterations in Steroid Refractory Active Colitis UlcerosaCompletedNCT03460847
- Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia PatientsCompletedNCT03452501
- Combined Nutritional Therapies for the Treatment of Ulcerative ColitisTerminatedNCT03444311Not applicable
- Role of Intestinal Protozoa and Helminths in the Course of Ulcerative ColitisActive, not recruitingNCT03441893Phase 1/2
- The Effect of Intestinal Microbiota Transplantation for Inflammatory Bowel DiseasesCompletedNCT03426683Not applicable
- PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative ColitisTerminatedNCT03415711Not applicable
- To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative ColitisCompletedNCT03412682Phase 3
- Monocultivar Coratina Extra Virgin Olive Oil in UC PatientsStatus unknownNCT03408847Not applicable